MEK Inhibition Enhances Presentation of Targetable MHC-I Tumor Antigens in Mutant Melanomas
Year: 2022
Type: preprint
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.4018615
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4226309151
